Curiox Biosystems Co. Ltd (Curiox), a leader in the innovation of life science research technologies, and Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, announce a strategic partnership to provide researchers with a one-stop solution for hands-free washed sample preparation for flow cytometry.
The agreement combines the Laminar flow-based gentle liquid exchange technology known as C-FREE™ technology from Curiox with the comprehensive suite of DURAClone dry pre-formulated antibody panels and customized DURA Innovations dry reagent antibody cocktails from Beckman Coulter Life Sciences. This workflow solution overcomes longstanding challenges faced by researchers worldwide, including the need for highly standardized, reproducible, and automated sample preparation for flow cytometry laboratories.
“Our alliance with Beckman Coulter Life Sciences is not just about combining technologies; it’s about combining our strengths to empower the scientific community,” said Namyong Kim. PhD, CEO of Curiox Biosystems. “By addressing the challenges of standardization, automation, and reproducibility head-on, we are paving the way for significant advancements in research and healthcare.”
“Speed and accuracy are of the utmost importance in delivering results to researchers to enable them to make critical decisions on their journey to pioneering new discoveries,” said Pietro Lopriore, Vice President and General Manager of Flow Cytometry at Beckman Coulter Life Sciences. “This partnership presents an exciting step forward in redefining the standards of quality and efficiency in flow cytometry research. By being a trusted partner to the scientific community, we’re able to combine complementary technologies to unite in a common goal of advancing research to positively impact lives.”
Source: PRNewsWire